Health Condition 1: N200- Calculus of kidney
Conditions
Interventions
Intervention1: 0.75% heavy ROPIVACAINE: Route- intra thecal
Volume - 4ml/30mg
Frequency- once at the beginning of procedure
Control Intervention1: 0.5% bupivacaine heavy: Volume- 4ml/20mg
Route- intr
Sponsors
Netaji Subhash Chandra Bose Superspeciality Hospital
Eligibility
Inclusion criteria
Inclusion criteria: ASA1-2 PATIENTS POSTED FOR PERCUTANEOUS NEPHROLITHOTOMY UNDER SPINAL ANAESTHESIA
Exclusion criteria
Exclusion criteria: PREGNANT PATIENTS ALLERGY TO EITHER DRUGS USED IN THE STUDY EMERGENCY CASES PATIENT REFUSAL TO PARTICIPATE IN THE STUDY
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate and compare the following parameters in patients receiving either 0.75% Ropivacaine heavy or 0.5% Bupivacaine heavy intrathecally for subarachnoid block: -intra-operative haemodynamic response - intra-operative side effects - efficacy of the drug volume -Onset and duration of sensory and motor blockTimepoint: hemodynamics - fall more than 20% of baseline drug volume - 4ml of either drug duration of block - varies | — |
Secondary
| Measure | Time frame |
|---|---|
| to compare anaesthetic effects of ropivacainein subarachnoid block with bupivacaine in patients undergoing percutaneous cystonephrolithotomy under spinal anaesthesia (PCNL)Timepoint: duration of the surgery | — |
Countries
India
Contacts
Public ContactJoti Chunilal Kanoujiya
netaji subhash chandra bose superspeciality hospital
Outcome results
None listed